OctM pathway control state

From Bioblast
Revision as of 03:56, 19 July 2022 by Gnaiger Erich (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)


high-resolution terminology - matching measurements at high-resolution


OctM pathway control state

Description

OctM: Octanoylcarnitine & Malate.

MitoPathway control state: F

SUIT protocols: SUIT-002, SUIT-015, SUIT-016, SUIT-017

Respiratory stimulation of the FAO-pathway, F, by fatty acid FA in the presence of malate M. Malate is a type N substrate (N), required for the F-pathway. In the presence of anaplerotic pathways (e.g., mitochondrial malic enzyme, mtME) the F-pathway capacity is overestimated, if there is an added contribution of NADH-linked respiration, F(N) (see SUIT-002). The FA concentration has to be optimized to saturate the FAO-pathway, without inhibiting or uncoupling respiration. Low concentration of malate, typically 0.1 mM, does not saturate the N-pathway; but saturates the F-pathway. High concentration of malate, typically 2 mM, saturates the N-pathway.

Abbreviation: OctM

Reference: MiPNet21.06 SUIT RP, SUIT reference protocol

More details
Β» Fatty acid oxidation pathway control state

OctML

FAO in the LEAK state can be evaluated in the following SUIT protocols:

OctMP

FAO in the OXPHOS state can be evaluated in the following SUIT protocols:

OctME

FAO in the ET state can be evaluated in the following SUIT protocols:



MitoPedia concepts: SUIT state 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.